Tag: Drug manufacturing

The global market for pilocarpine hydrochloride, the primary form of the drug, was valued at over $450 million in 2024 and is projected to grow significantly by 2033. Understanding what is the price of pilocarpine raw material requires a look beyond simple retail costs, as bulk pricing for Active Pharmaceutical Ingredients (API) is influenced by complex market dynamics.

The number of drug shortages in the U.S. is at its highest since 2001, affecting numerous critical medications. The ongoing triamcinolone backorder is a prime example of this widespread issue, with various manufacturers facing challenges that disrupt the supply chain and impact patient care.

In pharmacology and medicine, the acronym DSP doesn't refer to just one thing, creating confusion for patients and professionals alike. To clarify, this guide explores the primary uses for **what is a DSP used for?** in medication, from Downstream Processing in drug manufacturing to the role of a Direct Support Professional in patient care.

According to Drugs.com, all strengths of the cholesterol medication Altoprev have been discontinued, and its manufacturer was Covis Pharma. Discover the history of this drug and who is the manufacturer of Altoprev, the extended-release lovastatin tablet, as well as its availability and alternatives.

While the first FDA-approved 3D-printed drug was introduced in 2015, the medication known as 'nuking 3D tablet' is not a product of this technology but rather a brand-name combination drug used to treat nerve pain and seizures. Understanding the difference is crucial for patients and those interested in the future of medical technology.

In the highly regulated pharmaceutical industry, every batch of medication or raw material must be tested rigorously for quality and purity. A Certificate of Analysis, or COA, is a document that encapsulates the results of this crucial testing, serving as a pillar of patient safety and regulatory compliance.

According to the U.S. Food and Drug Administration (FDA), an estimated 80% of active pharmaceutical ingredients (APIs) used in the United States are manufactured overseas, making global supply chain transparency critical. Understanding **What does API stand for in FDA?** is essential for comprehending the foundational element of every medication: the active ingredient that produces the drug's intended effects.

With only about 10% of new drug candidates in preclinical development successfully reaching the market, the importance of a robust development process cannot be overstated. This is where the crucial field of F&D, or Formulation and Development, steps in, translating a discovered drug molecule into a patient-ready medicine.

While generic progesterone is now more accessible, historical context reveals that early extraction from animal sources was difficult and prohibitively expensive, costing up to $1,000 per gram. Modern pricing dynamics for progesterone are influenced by manufacturing processes, market competition, and specific drug formulations.

The brand-name medication Atarax was discontinued in the U.S. in 2021 due to business-related factors by its manufacturer, and not for any safety or effectiveness reasons, according to the FDA. Patients who relied on Atarax should know that its active ingredient, hydroxyzine hydrochloride, remains widely available through generic versions.